Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling
Shizuka Otsuka, … , Roberto Weigert, Jonathan D. Ashwell
Shizuka Otsuka, … , Roberto Weigert, Jonathan D. Ashwell
Published April 6, 2021
Citation Information: J Clin Invest. 2021;131(11):e147683. https://doi.org/10.1172/JCI147683.
View: Text | PDF
Research Article Immunology

Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling

  • Text
  • PDF
Abstract

Inhibitors of calcineurin phosphatase activity (CNIs) such as cyclosporin A (CsA) are widely used to treat tissue transplant rejection and acute graft-versus-host disease (aGVHD), for which inhibition of gene expression dependent on nuclear factor of activated T cells (NFAT) is the mechanistic paradigm. We recently reported that CNIs inhibit TCR-proximal signaling by preventing calcineurin-mediated dephosphorylation of LckS59, an inhibitory modification, raising the possibility of another mechanism by which CNIs suppress immune responses. Here we used T cells from mice that express LckS59A, which cannot accept a phosphate at residue 59, to initiate aGVHD. Although CsA inhibited NFAT-dependent gene upregulation in allo-aggressive T cells expressing either LckWT or LckS59A, it was ineffective in treating disease when the T cells expressed LckS59A. Two important NFAT-independent T cell functions were found to be CsA-resistant in LckS59A T cells: upregulation of the cytolytic protein perforin in tissue-infiltrating CD8+ T cells and antigen-specific T/DC adhesion and clustering in lymph nodes. These results demonstrate that effective treatment of aGVHD by CsA requires NFAT-independent inhibition of TCR signaling. Given that NFATs are widely expressed and off-target effects are a major limitation in CNI use, it is possible that targeting TCR-associated calcineurin directly may provide effective therapies with less toxicity.

Authors

Shizuka Otsuka, Nicolas Melis, Matthias M. Gaida, Debjani Dutta, Roberto Weigert, Jonathan D. Ashwell

×

Figure 7

T/DC interactions are inhibited by CsA via suppression of TCR proximal signaling.

Options: View larger image (or click on image) Download as PowerPoint
T/DC interactions are inhibited by CsA via suppression of TCR proximal s...
Mice were injected in the footpad with gp33 or OVA-p pulsed DCs labeled with Deep Red Dye. After 18 to 20 hours, recipients were injected i.v. with green CMFDA-labeled P14 WT or LckS59A T cells. pLNs were collected at the indicated times, cleared, and imaged by 2-photon microscopy. (A) Example images (20 μm thick) at the indicated times are shown (DCs are red, P14 T cells are green). Arrows (white) indicate T/DC clusters. (B) The percentage of T/DC clusters as analyzed by Imaris software. Data were pooled from 3 or 4 experiments. (C) The proportion of small (3–4 cells), medium (5–9 cells), and large (10 or more cells) clusters in the total number of T cell clusters. The number of T cells per cluster as analyzed by Imaris software. Data were pooled from 2 to 4 independent experiments. (D–I) Mice were injected i.p. with CsA or PBS at the time of DC transfer and again the time of T cell transfer. pLNs were removed at 3 (D–F) or 6 (G–I) hours after T cell injection and imaged. Representative images are shown in (D) and (G). The percentage of T/DC clusters (E and H) and the number of T cells per cluster (F and I) were analyzed by Imaris software. Data were pooled from 3 to 4 independent experiments (E and H) or 3 independent experiments (F and I). (J–L) CsA was injected 1 hour before collecting pLNs. Representative images are shown in (J). The percentage of T/DC clusters (K) and the number of T cells per cluster (L) were determined with Imaris software. Data were pooled from 3 or 4 independent experiments (K) or 3 independent experiments (L). The graphs show the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.0001 by 2-way ANOVA with Tukey’s multiple-comparison post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts